NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 993 coverNEUROPROTECTIVE AGENTS: Sixth International Conference Copyright © 2003 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by REITER, R. J.
Articles by TAN, D. X.
Search for Related Content
PubMed
PubMed Citation
Articles by REITER, R. J.
Articles by TAN, D. X.
Annals of the New York Academy of Sciences 993:35-47 (2003)
© 2003 New York Academy of Sciences

Melatonin Ameliorates Neurologic Damage and Neurophysiologic Deficits in Experimental Models of Stroke

RUSSEL J. REITER, ROSA M. SAINZ, SILVIA LOPEZ-BURILLO, JUAN C. MAYO, LUCIEN C. MANCHESTER AND DUN XIAN TAN

Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas, USA

Address for correspondence: Russel J. Reiter, Ph.D., Department of Cellular and Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA. Voice: 210-567-3859; fax: 210-567-6948.
reiter{at}uthscsa.edu
Ann. N.Y. Acad. Sci. 993: 35-47 (2003).

This review summarizes the numerous reports that have documented the neuroprotective actions of melatonin in experimental models of ischemia/reperfusion injury (stroke). In these investigations, which have used three species (rat, gerbil, and cat), melatonin was universally found to reduce brain damage that normally occurs as a consequence of the temporary interruption of blood flow followed by the reflow of oxygenated blood to the brain. The exogenous administration of melatonin in these experimental stroke models reduced infarct volume, lowered the frequency of apoptosis, increased the number of surviving neurons, reduced reactive gliosis, lowered the oxidation of neural lipids and oxidatively damaged DNA, induced bcl-2 gene expression (the activity of which improves cell survival), upregulated excision repair cross-complementing factor 6 (an essential gene for preferential DNA excision repair), restrained poly(ADP ribose) synthetase (which depletes cellular NAD resulting in the loss of ATP) activity, and improved neurophysiologic outcomes. Under no circumstances did melatonin exacerbate the damage associated with ischemia/reperfusion injury. As well as the beneficial pharmacologic actions of melatonin, several studies show that a relative deficiency of endogenous melatonin exaggerates neural damage due to stroke; this suggests that even physiologic concentrations of melatonin normally serve to protect the brain against damage. The primary action to explain melatonin's protective effects may relate to its ubiquitous direct and indirect antioxidative actions, although other beneficial functions of melatonin are not precluded.

Key Words: ischemia/reperfusion injury • brain • stroke • melatonin • antioxidant • neuroprotection




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
R. J. Reiter, D.-x. Tan, J. Leon, U. Kilic, and E. Kilic
When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke
Experimental Biology and Medicine, February 1, 2005; 230(2): 104 - 117.
[Abstract] [Full Text] [PDF]



footerLeft footerRight